Lynne S. Gearinger

Efficacy and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% Administered Twice Daily for 3 Days in the Treatment of Bacterial Conjunctivitis: A Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study in Adults and Children

Bruce E. Silverstein, Catherine Allaire, Kirk Bateman et al. · Clinical Therapeutics · 2011 · 48 citations

Ocular Disease, Ophthalmology, Antibiotics +7

Besifloxacin Ophthalmic Suspension 0.6% Administered Twice Daily for 3 Days in the Treatment of Bacterial Conjunctivitis in Adults and Children

J. DeLeon, Bruce E. Silverstein, Catherine Allaire et al. · Clinical Drug Investigation · 2012 · 26 citations

Ocular Disease, Ophthalmology, Pediatric Ophthalmology +3

Microbiological Etiology and Susceptibility of Bacterial Conjunctivitis Isolates from Clinical Trials with Ophthalmic, Twice-Daily Besifloxacin

Wolfgang Haas, Lynne S. Gearinger, Christine K. Hesje et al. · Advances in Therapy · 2012 · 25 citations

Twice-daily Besifloxacin, Ocular Disease, Ophthalmology +10

Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections

Laura Clark, Bruce E. Silverstein, Timothy W. Morris et al. · Clinical ophthalmology · 2012 · 18 citations · Full text

The Safety of Besifloxacin Ophthalmic Suspension 0.6 % Used Three Times Daily for 7 Days in the Treatment of Bacterial Conjunctivitis

Ranjan Malhotra, Stacey Ackerman, Lynne S. Gearinger et al. · Drugs in R&D · 2013 · 16 citations · Full text